Phase II randomized, open-label, crossover, single-dose study investigating bioavailability and pharmacokinetics of testosterone undecanoate [LPCN-1021] as a function of food fat content in hypogonadal males.
Phase of Trial: Phase II
Latest Information Update: 17 Jun 2015
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics; Registrational
- Sponsors Lipocine
- 17 Jun 2015 Status changed from recruiting to completed according to a Lipocine Inc. media release.
- 15 Jun 2015 Topline results published in a Lipocine Inc. media release.
- 26 Mar 2015 New trial record